References
- Chiche L, Adam JP. Diagnosis and management of benign liver tumors. Semin Liver Dis 2013;33:236–47.
- Heikkinen M, Rasanen H, Farkkila M. Clinical value of ultrasound in the evaluation of dyspepsia in primary health care. Scand J Gastroenterol 2005;40:980–4.
- Karhunen PJ, Penttila A, Liesto K, Mannikko A, Mottonen MM. Occurrence of benign hepatocellular tumors in alcoholic men. Acta Pathol Microbiol Immunol Scand A 1986;94:141–7.
- El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999;340:745–50.
- Murakami T, Oi H, Hori M, Kim T, Takahashi S, Tomoda K, et al. Helical CT during arterial portography and hepatic arteriography for detecting hypervascular hepatocellular carcinoma. AJR Am J Roentgenol 1997;169:131–5.
- Hussain SM, Semelka RC. Liver masses. Magn Reson Imaging Clin N Am 2005;13:255–75.
- Balci NC, Befeler AS, Leiva P, Pilgram TK, Havlioglu N. Imaging of liver disease: comparison between quadruple-phase multidetector computed tomography and magnetic resonance imaging. J Gastroenterol Hepatol 2008;23:1520–7.
- van Kouwen MC, Oyen WJ, Nagengast FM, Jansen JB, Drenth JP. FDG-PET scanning in the diagnosis of gastrointestinal cancers. Scand J Gastroenterol Suppl 2004;241:85–92.
- Berland LL, Silverman SG, Gore RM, Mayo-Smith WW, Megibow AJ, Yee J, et al. Managing incidental findings on abdominal CT: white paper of the ACR incidental findings committee. J Am Coll Radiol 2010;7:754–73.
- Casarella WJ. Current structure and purpose of the American Board of Radiology examination process. Acad Radiol 2001;8:1260–1.
- Huo TI, Huang YH, Chiang JH, Wu JC, Lee PC, Chi CW, et al. Survival impact of delayed treatment in patients with hepatocellular carcinoma undergoing locoregional therapy: is there a lead-time bias? Scand J Gastroenterol 2007;42:485–92.
- Croome KP, Chudzinski R, Hanto DW. Increasing time delay from presentation until surgical referral for hepatobiliary malignancies. HPB (Oxford) 2010;12:644–8.
- Heuman DM, Gilles HS, Solomon C, Bajaj JS. Should a radiological diagnosis of hepatocellular carcinoma be routinely confirmed by a biopsy? No. Eur J Intern Med 2012;23:37–9.
- Anders RA, Kamel IR. Biopsy considerations in the diagnosis of hepatic masses. Clin Gastroenterol Hepatol 2007;5:541–4.
- Zech CJ, Grazioli L, Breuer J, Reiser MF, Schoenberg SO. Diagnostic performance and description of morphological features of focal nodular hyperplasia in Gd-EOB-DTPA-enhanced liver magnetic resonance imaging: results of a multicenter trial. Invest Radiol 2008;43:504–11.
- Maniam S, Szklaruk J. Magnetic resonance imaging: review of imaging techniques and overview of liver imaging. World J Radiol 2010;2:309–22.
- Yoon SS, Charny CK, Fong Y, Jarnagin WR, Schwartz LH, Blumgart LH, et al. Diagnosis, management, and outcomes of 115 patients with hepatic hemangioma. J Am Coll Surg 2003;197:392–402.
- Chung YE, Kim MJ, Kim YE, Park MS, Choi JY, Kim KW. Characterization of incidental liver lesions: comparison of multidetector CT versus Gd-EOB-DTPA-enhanced MR imaging. PLoS One 2013;8:e66141.
- Soussan M, Aube C, Bahrami S, Boursier J, Valla DC, Vilgrain V. Incidental focal solid liver lesions: diagnostic performance of contrast-enhanced ultrasound and MR imaging. Eur Radiol 2010;20:1715–25.
- Bartolotta TV, Taibbi A, Midiri M, Matranga D, Solbiati L, Lagalla R. Indeterminate focal liver lesions incidentally discovered at gray-scale US: role of contrast-enhanced sonography. Invest Radiol 2011;46:106–15.
- Claudon M, Cosgrove D, Albrecht T, Bolondi L, Bosio M, Calliada F, et al. Guidelines and good clinical practice recommendations for Contrast Enhanced Ultrasound (CEUS) – update 2008. Ultraschall Med 2008;29:28–44.
- Claudon M, Dietrich CF, Choi BI, Cosgrove DO, Kudo M, Nolsøe CP, et al. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver–update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. Ultraschall Med 2013;34:11–29.